Hepatitis C virus infection and genotypes in blood donors

Authors

  • M Mahmoudian Shooshtari Assistant professor of Research center, Iranian Blood Transfusion Organization (IBTO), Tehran, Iran.
  • Z Sharifi Assistant professor of Research center, Iranian Blood Transfusion Organization (IBTO), Tehran, Iran.
Abstract:

Abstract: Genotyping of the hepatitis C virus (HCV) is important for designing therapeutic strategies and regional specific diagnostic assays. The aim of this study was to identify the HCV genotypes in HCV infected blood donors. This is the first report on HCV genotypes in blood donors in Iran. In this cross-sectional study, 103 blood donors with hepatitis C were investigated for HCV genotypes. HCV genotyping was carried out using type-specific primers from the core region of the viral genome. From 103 blood donors, only96 cases had genotypes which could be typed. The highest frequency genotype 1a, with 53 (51.5%) of subjects. Genotype 3a and 1b were the other frequent genotypes with 39 (37.9 %) and 4 (3.9%)   subjects, respec-tively. These results indicate that the dominant HCV genotypes among blood donors were 1a, 3a and 1b respectively. It was also noticed that more of the blood donors infected with genotypes 1a and 3a had history of intravenous drug abuse and tattooing.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

hepatitis c virus infection and genotypes in blood donors

abstract: genotyping of the hepatitis c virus (hcv) is important for designing therapeutic strategies and regional specific diagnostic assays. the aim of this study was to identify the hcv genotypes in hcv infected blood donors. this is the first report on hcv genotypes in blood donors in iran. in this cross-sectional study, 103 blood donors with hepatitis c were investigated for hcv genotypes....

full text

Hepatitis C virus genotypes in patients and blood donors--Quebec.

Hepatitis C is currently and will continue to be an important public health problem worldwide. Seroprevalence rates in blood donors range from 0.05% to 2.5%. An exceptionally high rate (13% to 20%) is encountered in Egyptian donors and the reason for this remains unknown. In North America, the seroprevalence rate among volunteer blood donors varies from 0.05% to 0.7%. In the general population ...

full text

Prevalence of Hepatitis B, C and HIV Infection in Blood Donors in Zanjan, 2005-2006

Background and Objectives: Providing safe blood and prevention of blood-borne infections are among the most important purposes of the Blood Transfusion Organization. The aim of this study was to describe the prevalence of Hepatitis B, C and HIV infection and their determinants in Zanjan blood donors from 2005 to 2006. Material and Methods: In this cross-sectional study, the prevalence of Hepati...

full text

Hepatitis E Virus and Serum Level Aminotransferases in Blood Donors

Background: Hepatitis E virus (HEV) infection is a self-limiting viral infection that can lead to severe complications and death. In different regions the epidemiology of this infection varies. In this study we evaluated the seroepidemiology of hepatitis E infection in Jahrom, a city in southern Iran. Methods: This was a cross-sectional descriptive study of serum samples from 477 subjects, i...

full text

Prevalence and genotypes of GB virus C/hepatitis G virus among blood donors in Central Brazil.

A survey was conducted in a blood donor population of Central Brazil aiming to investigate the prevalence of GB virus C (GBV-C)/hepatitis G virus (HGV) infection and also to analyze the virus genotypes distribution. A total of 241 voluntary blood donors were interviewed at the State Blood Bank in Goiânia, State of Goiás, Brazil. Blood samples were collected and serum samples tested for GBV-C/HG...

full text

Hepatitis C Virus in Blood Donors, Brazil

tivitis during July–September 2007. Reported treatment included home remedies and a nonprescription, locally available, cream containing a sulfa drug. Review of municipal hospital records during June 1–September 30, 2007, identifi ed no additional cases of conjunctivitis. After the last case-patient died, 17 other persons were identifi ed with purulent conjunctivitis: 4 at the municipal hospita...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 1  issue None

pages  17- 22

publication date 2007-11

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023